-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

655. Multiple Myeloma: Cellular Therapies: Poster II

Symposia: Multiple Myeloma: Cellular Therapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Debashree Basudhar1*, Dante Descalzi-Montoya1*, Hao Tang1*, Minshi Wang1*, Fan Wu1*, P. Leif Bergsagel, MD2, Xavier Leleu3, Daniela Hosseyni1*, Maria Chaudhry1*, Nathan Martin1* and Ethan G. Thompson, PhD1*

1Bristol Myers Squibb, Princeton, NJ
2Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
3CHU La Milétrie, Poitiers, France

Philipp Berning, MD1*, Markus Maulhardt2*, Hristo Boyadzhiev3,4*, Anca Maria Albici5*, Snjezana Janjetovic6*, Anna Ossami Saidy7*, Christian R Schultze-Florey, MD8*, Simon Call1*, Natalie Schub9*, Annamaria Brioli, MD, PhD8*, Michael Daskalakis10*, Juliane Knust, MD2*, Justin Hasenkamp2*, Matthias Stelljes, MD1*, Cyrus Khandanpour11, Ulrike Bacher10*, Christine Hanoun12*, Florian Heidel, MD8, Hans Christian Reinhardt, MD12, Georg Lenz1, Gerald Wulf2*, Friedrich Stölzel9*, Bastian von Tresckow12, Thomas Pabst3 and Evgenii Shumilov1*

1Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
2Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
3Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
4Habichtswald Hospital, Kassel, Germany
5Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
6Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
7Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch Berlin, Berlin, Germany
8Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
9Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel, Germany
10Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
11Department of Hematology and Oncology, University Hospital Schleswig-Holstein, University of Luebeck, Luebeck, Germany
12Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Yue Zhou1,2*, Juan Chen1,2*, Qingya Cui1,2*, Haiping Dai2,3*, Zheng Li, MD1,2*, Jia Yin1,2*, Wei Cui1,2*, Mengyun Li1,2*, Xuekai Li1,2*, Xin Zhang1,2*, Feiran Gong1,2*, Xiaming Zhu1,2*, Liqing Kang4*, Lei Yu4*, Depei Wu, MD, PhD5,6 and Xiaowen Tang1,2*

1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
2Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
3The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
4Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
5Institute of Blood and Marrow Transplantation, Suzhou, China
6The First Affiliated Hospital of Soochow University, Suzhou, China

Wenqiang Yan1*, Chenxing DU2*, Rui Lv3*, Tengteng Yu4*, Shuaishuai Zhang, MD4*, Tingyu Wang5*, Weiwei Sui, MD2*, Shuhui Deng6*, Yan Xu, MD7*, Shuhua Yi, MD8*, Dehui Zou9*, Lu-Gui Qiu2 and Gang An2*

1State Key Laboratory of Experimental Hematology, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, CHN
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sci, Tian Jin, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Brookline, MA
7State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Boston, MA
8State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
9Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Scienfor Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Yuntong Liu1*, Weiwei Sui, MD2*, Rui Lyu, MD3*, Chenxing DU2*, Shuaishuai Zhang, MD4*, Tengteng Yu4*, Jingyu Xu2*, Wenqiang Yan5*, Yuting Yan, MD4*, Wei Liu2*, Yi Wang2*, Qi Wang, MD3*, Yan Xu, MD6*, Shuhua Yi7*, Dehui Zou2*, Lu-Gui Qiu2 and Gang An2*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, UT, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Boston, MA
7National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Lixia Ma1*, Rui Liu1*, Fan Yang1*, Yuelu Guo1*, Yimeng Dou1*, Biping Deng, BS, MD2*, Zhonghua Fu1*, Xiaoyan Ke1* and Kai Hu, MD1

1Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Hospital, Beijing, China
2Department of Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing, China

Barry Paul, MD, MS1, Madhav V. Dhodapkar, MD PhD2, Melissa Alsina, MD3*, Jesús G. Berdeja, MD4, Shambavi Richard, MD5, Ravi Vij, MD, MBA6, Xavier Leleu7, Daniel N. Egan, MD8, P. Leif Bergsagel, MD9, Ran Reshef, MD, MSc10, Saad Z. Usmani, MD11, Anna Truppel-Hartmann, MD12*, Debashree Basudhar13*, Ethan G. Thompson, PhD13*, Fan Wu13*, Laurie Eliason13*, Soyun Park13*, Sinhan Tran13*, Maria Chaudhry13*, David S. Siegel, MD, PhD14 and Krina K. Patel, MD, MSc15

1Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
2Winship Cancer Institute of Emory University, Atlanta, GA
3Moffitt Cancer Center, Tampa, FL
4Tennessee Oncology, Nashville, TN
5Mount Sinai Hospital, New York, NY
6Division of Oncology, Washington University School of Medicine, St. Louis, MO
7CHU La Milétrie, Poitiers, France
8Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
9Mayo Clinic Arizona, Phoenix, AZ
10Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
11Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
122seventy bio, Cambridge, MA
13Bristol Myers Squibb, Princeton, NJ
14John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
15MD Anderson Cancer Center, University of Texas, Houston, TX

Jingyu Xu1*, Shuaishuai Zhang, MD2*, Wenqiang Yan3*, Yuntong Liu4*, Rui Lyu, MD5*, Chenxing DU1*, Weiwei Sui, MD5*, Lu-Gui Qiu, MD6,7 and Gang An6,8*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, TIANJIN, CHN
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, UT, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
7Institute of Multiple Myeloma, Beijing GoBroad Boren Hospital, BEIJING, China
8Institute of Multiple Myeloma, Beijing GoBroad Boren Hospital, Beijing, China

Nieves Lopez-Muñoz1*, Noffar Bar, MD2, Joris Diels3*, Suzy van Sanden3*, João Mendes4*, Seina Lee4*, Teresa Hernando5*, Nikoletta Lendvai6*, Nitin Patel7*, Tadao Ishida8, Jeremy Er9, Simon J Harrison, MBBS, PhD10 and Urvi A. Shah, MD11

1Hospital Universitario 12 de Octubre, Madrid, Spain
2Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
3Janssen Pharmaceutica NV, Beerse, Belgium
4Janssen Global Services, LLC, Raritan, NJ
5Janssen-Cilag, Madrid, Spain
6Oncology Clinical Development, Johnson and Johnson Innovative Medicine, Bridgewater, NJ
7Legend Biotech USA Inc., Somerset, NJ
8Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
9Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
10Clinical Haematology and Centre of Excellence for Cellular Immunotherapy, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
11Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

*signifies non-member of ASH